Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 May 6;14(9):e038832.
doi: 10.1161/JAHA.124.038832. Epub 2025 Apr 17.

Patterns of Postablation Recurrence and Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation

Affiliations
Multicenter Study

Patterns of Postablation Recurrence and Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation

Sitong Li et al. J Am Heart Assoc. .

Abstract

Background: Atrial arrhythmia recurrence after atrial fibrillation (AF) catheter ablation is conventionally assessed as a binary end point. However, the prognostic value of recurrence patterns is less studied.

Methods and results: This study included patients undergoing catheter ablation from the multicenter China Atrial Fibrillation Registry study (2011-2022). Postablation AF patterns within 1 year were categorized as nonrecurrence, paroxysmal AF recurrence, or persistent AF (PersAF) recurrence. Cardiovascular outcomes included cardiovascular death, thromboembolism, and cardiovascular hospitalization. Cox proportional models with landmark analysis were used to assess the relationship between recurrence patterns and outcomes. Sensitivity analyses were conducted using Fine-Gray models, considering death unrelated to the outcomes as the competing risk and evaluating 2-year recurrence patterns. Among 13 811 patients (mean age, 60.5±10.8 years; 66.1% men), those with preablation PersAF, prior stroke/transient ischemic attack/systemic embolism, and increased left atrial diameter were more likely to develop PersAF postablation. Compared with nonrecurrence, PersAF recurrence was associated with higher risks of cardiovascular death (hazard ratio [HR], 2.03 [95% CI, 1.20-3.43]; P=0.009), thromboembolism (HR, 1.50 [95% CI, 1.09-2.06]; P=0.012), and cardiovascular hospitalization (HR, 1.74 [95% CI, 1.56-1.94]; P<0.001) during a median follow-up of 3.02 years (interquartile range, 1.44-5.03 years), while paroxysmal AF recurrence was only significantly associated with an increased risk of cardiovascular hospitalization (HR, 1.98 [95% CI, 1.83-2.14], P<0.001). Sensitivity analyses yielded consistent results.

Conclusions: Postablation PersAF recurrence was associated with significantly higher risks of cardiovascular death and thromboembolism, compared with paroxysmal AF recurrence and nonrecurrence, indicating the prognostic importance of recurrence patterns.

Registration: URL: www.chictr.org.cn/; unique identifier: ChiCTR-OCH-13003729.

Keywords: atrial fibrillation; cardiovascular death; catheter ablation; patterns of recurrence; thromboembolism.

PubMed Disclaimer

Conflict of interest statement

Dr Ma reports honoraria from Bristol‐Myers Squibb, Pfizer, Johnson & Johnson, Boehringer‐Ingelheim, Bayer, and AstraZeneca for giving lectures. The remaining authors have no disclosures to report.

Figures

Figure 1
Figure 1. Associations between AF recurrence patterns and cardiovascular outcomes.
*Adjusted for age, sex, body mass index, preablation AF pattern, history of heart failure, hypertension, diabetes, stroke/transient ischemic attack/systemic embolism, coronary artery disease, and oral anticoagulation status at 12 months. AF indicates atrial fibrillation; HR, hazard ratio; PAF, paroxysmal atrial fibrillation; and PersAF, persistent atrial fibrillation.
Figure 2
Figure 2. Proportions of postablation recurrence patterns among patients with paroxysmal or persistent atrial fibrillation before ablation.
PAF indicates paroxysmal atrial fibrillation; and PersAF, persistent atrial fibrillation.
Figure 3
Figure 3. Association between AF recurrence patterns and cardiovascular outcomes stratified by preablation AF patterns.
Among 8778 patients with preablation PAF, 6566 were categorized as nonrecurrence, 1890 as PAF recurrence, and 322 as PersAF recurrence. Among 5033 patients with preablation PersAF, 3551 were categorized as nonrecurrence, 521 as PAF recurrence, and 961 as PersAF recurrence. *Adjusted for age, sex, body mass index, history of heart failure, hypertension, diabetes, stroke/transient ischemic attack/systemic embolism, coronary artery disease, and oral anticoagulantion status at 12 months. AF indicates atrial fibrillation; HR, hazard ratio; PAF, paroxysmal atrial fibrillation; and PersAF, persistent atrial fibrillation.

Similar articles

References

    1. Perino AC, Fan J, Askari M, Heidenreich PA, Keung E, Raitt MH, Piccini JP, Ziegler PD, Turakhia MP. Practice variation in anticoagulation prescription and outcomes after device‐detected atrial fibrillation. Circulation. 2019;139:2502–2512. doi: 10.1161/circulationaha.118.038988 - DOI - PMC - PubMed
    1. Go AS, Reynolds K, Yang J, Gupta N, Lenane J, Sung SH, Harrison TN, Liu TI, Solomon MD. Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP‐RHYTHM study. JAMA Cardiol. 2018;3:601–608. doi: 10.1001/jamacardio.2018.1176 - DOI - PMC - PubMed
    1. Peigh G, Zhou J, Rosemas SC, Roberts AI, Longacre C, Trinh K, Nayak T, Soderlund D, Passman RS. Association of atrial fibrillation burden and mortality among patients with cardiac implantable electronic devices. Circulation. 2024;150:350–361. doi: 10.1161/circulationaha.124.069757 - DOI - PMC - PubMed
    1. Chew DS, Li Z, Steinberg BA, O'Brien EC, Pritchard J, Bunch TJ, Mark DB, Patel MR, Nabutovsky Y, Greiner MA, et al. Arrhythmic burden and the risk of cardiovascular outcomes in patients with paroxysmal atrial fibrillation and cardiac implanted electronic devices. Circ Arrhythm Electrophysiol. 2022;15:e010304. doi: 10.1161/circep.121.010304 - DOI - PubMed
    1. Yang WY, Du X, Fawzy AM, He L, Li HW, Dong JZ, Lip GYH, Ma CS. Associations of atrial fibrillation progression with clinical risk factors and clinical prognosis: a report from the Chinese atrial fibrillation registry study. J Cardiovasc Electrophysiol. 2021;32:333–341. doi: 10.1111/jce.14826 - DOI - PubMed

Publication types

LinkOut - more resources